Highly expressed RFC3 has been confirmed to be a predictive gene in Kaposi’s sarcoma [41], breast cancer [42], esophageal adenocarcinoma [43], and hepatocellular carcinoma [44]. This evidence concerns the gene RFC3 and hepatocellular carcinoma.